Harnessing the Power of Advanced Multimodal Approaches to GPCR Drug Discovery

The 2025 Molecular Pharmacology Gordon Research Conference and Seminar (GRC/GRS), set to take place in Ventura, California, is poised to be a pivotal event that redefines the exploration of G protein-coupled receptors (GPCRs) in health and disease, unveiling new horizons in GPCR research through advanced multimodal approaches. As the cornerstone of this year's theme, "Harnessing the Power of Advanced Multimodal Approaches to GPCR Drug Discovery," we are committed to fostering a multidisciplinary environment where the brightest minds from academia, government, and industry can come together. Our agenda is carefully designed to highlight the forefront of GPCR research, including the integration of artificial intelligence (AI) and machine learning with both traditional and novel experimental techniques to unlock the full therapeutic potential of GPCRs. The conference will feature a dynamic array of presentations and interactive sessions, highlighting breakthroughs in understanding GPCR signaling mechanisms, and their role as targets for new precision therapies for a myriad of human diseases. Participants will have a unique opportunity to engage in discussions that bridge the gap between computational and experimental methodologies, fostering collaborations that could revolutionize therapeutic strategies for a host of disease conditions. By exploring the synergy between advanced multimodal approaches, the conference aims to accelerate the journey from conceptual frameworks to clinical applications, spotlighting novel targets and therapeutic candidates. Aligned with the GRC’s mission to cultivate a free-thinking, accessible, and egalitarian community, the 2025 Molecular Pharmacology GRC/GRS encourages scientists at all levels of their career to participate, share their insights, and contribute to the collective quest to address the most pressing questions in GPCR biology. Join us in Ventura for a transformative experience, where the fusion of technology and science opens new pathways to discovery, and where your contributions can help shape the future of molecular pharmacology and the development of therapies targeting GPCRs.

This conference is oversubscribed. Any new applications will be placed on the waitlist and reviewed as space becomes available.